Hospital Universitario Araba-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2023

  1. Development and Validation of a Prediction Model and Score for Transthyretin Cardiac Amyloidosis Diagnosis: T-Amylo

    JACC: Cardiovascular Imaging, Vol. 16, Núm. 12, pp. 1567-1580

2022

  1. Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198

  2. Knowledge about COVID-19 and vaccine acceptability among priority groups defined for vaccination: A cross-sectional study in Araba/Alava, Spain, before the vaccination against SARS-CoV-2

    Vaccine: X, Vol. 11

2021

  1. Prevalence and clinical outcomes of dystrophin-associated dilated cardiomyopathy without severe skeletal myopathy

    European Journal of Heart Failure, Vol. 23, Núm. 8, pp. 1276-1286

2020

  1. Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy

    Heart, Vol. 106, Núm. 17, pp. 1342-1348

2016

  1. Cardiac Arrhythmias and Pacing 2015: A Selection of Topical Issues

    Revista Espanola de Cardiologia, Vol. 69, Núm. 2, pp. 167-175

  2. Marfan Syndrome Caused by Somatic Mosaicism in an FBN1 Splicing Mutation

    Revista Espanola de Cardiologia, Vol. 69, Núm. 5, pp. 520-521

2011

  1. Ecocardiografía de contraste y supradesnivel del segmento ST

    Revista Espanola de Cardiologia